Incyte Corporation (INCY)
USD 60.96
(-2.4%)
USD 60.96
(-2.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.17 Billion USD | -9.23% |
| 2022 | -2.9 Billion USD | -43.67% |
| 2021 | -2.02 Billion USD | -36.87% |
| 2020 | -1.47 Billion USD | 17.04% |
| 2019 | -1.78 Billion USD | -55.41% |
| 2018 | -1.14 Billion USD | -30.96% |
| 2017 | -875.5 Million USD | -101467.05% |
| 2016 | -862 Thousand USD | -100.88% |
| 2015 | 98.45 Million USD | -58.43% |
| 2014 | 236.82 Million USD | 24.55% |
| 2013 | 190.13 Million USD | 77.67% |
| 2012 | 107.01 Million USD | 177.55% |
| 2011 | 38.55 Million USD | 130.98% |
| 2010 | -124.48 Million USD | -1761.8% |
| 2009 | -6.68 Million USD | -103.08% |
| 2008 | 217.4 Million USD | -21.71% |
| 2007 | 277.7 Million USD | -21.16% |
| 2006 | 352.24 Million USD | 6.62% |
| 2005 | 330.36 Million USD | 33.98% |
| 2004 | 246.58 Million USD | 78.57% |
| 2003 | 138.08 Million USD | -7.39% |
| 2002 | 149.1 Million USD | 9.74% |
| 2001 | 135.88 Million USD | 74.97% |
| 2000 | 77.65 Million USD | 342.68% |
| 1999 | -32 Million USD | 34.96% |
| 1998 | -49.2 Million USD | 1.6% |
| 1997 | -50 Million USD | -566.67% |
| 1996 | -7.5 Million USD | 27.18% |
| 1995 | -10.3 Million USD | -56.06% |
| 1994 | -6.6 Million USD | 55.1% |
| 1993 | -14.7 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.3 Billion USD | -4.21% |
| 2024 Q3 | -1.27 Billion USD | -33.47% |
| 2024 Q2 | -949.74 Million USD | 71.3% |
| 2023 Q2 | -3.09 Billion USD | -10.87% |
| 2023 FY | -3.17 Billion USD | -9.23% |
| 2023 Q3 | -3.19 Billion USD | -3.36% |
| 2023 Q4 | -3.17 Billion USD | 0.63% |
| 2023 Q1 | -2.78 Billion USD | 4.08% |
| 2022 Q3 | -2.64 Billion USD | -10.87% |
| 2022 Q2 | -2.38 Billion USD | -8.1% |
| 2022 FY | -2.9 Billion USD | -43.67% |
| 2022 Q4 | -2.9 Billion USD | -9.75% |
| 2022 Q1 | -2.2 Billion USD | -9.23% |
| 2021 Q1 | -1.63 Billion USD | -10.64% |
| 2021 Q4 | -2.02 Billion USD | -3.47% |
| 2021 FY | -2.02 Billion USD | -36.87% |
| 2021 Q3 | -1.95 Billion USD | -11.59% |
| 2021 Q2 | -1.75 Billion USD | -7.14% |
| 2020 FY | -1.47 Billion USD | 17.04% |
| 2020 Q4 | -1.47 Billion USD | -2.63% |
| 2020 Q1 | -982.82 Million USD | 44.84% |
| 2020 Q3 | -1.44 Billion USD | -13.86% |
| 2020 Q2 | -1.26 Billion USD | -28.71% |
| 2019 FY | -1.78 Billion USD | -55.41% |
| 2019 Q1 | -1.28 Billion USD | -11.82% |
| 2019 Q2 | -1.36 Billion USD | -6.54% |
| 2019 Q3 | -1.68 Billion USD | -23.28% |
| 2019 Q4 | -1.78 Billion USD | -5.81% |
| 2018 Q1 | -870.15 Million USD | 0.61% |
| 2018 Q3 | -1.08 Billion USD | -20.28% |
| 2018 Q4 | -1.14 Billion USD | -5.45% |
| 2018 FY | -1.14 Billion USD | -30.96% |
| 2018 Q2 | -903.94 Million USD | -3.88% |
| 2017 Q2 | -428.32 Million USD | -33.76% |
| 2017 Q3 | -1.1 Billion USD | -157.83% |
| 2017 Q4 | -875.5 Million USD | 20.72% |
| 2017 Q1 | -320.21 Million USD | -37048.38% |
| 2017 FY | -875.5 Million USD | -101467.05% |
| 2016 Q2 | 147.83 Million USD | 593.23% |
| 2016 Q3 | 63.33 Million USD | -57.16% |
| 2016 Q4 | -862 Thousand USD | -101.36% |
| 2016 FY | -862 Thousand USD | -100.88% |
| 2016 Q1 | -29.97 Million USD | -130.44% |
| 2015 Q1 | 275.72 Million USD | 16.43% |
| 2015 FY | 98.45 Million USD | -58.43% |
| 2015 Q4 | 98.45 Million USD | -44.73% |
| 2015 Q2 | 220.28 Million USD | -20.11% |
| 2015 Q3 | 178.13 Million USD | -19.14% |
| 2014 Q4 | 236.82 Million USD | -20.88% |
| 2014 Q1 | 228.63 Million USD | 20.25% |
| 2014 FY | 236.82 Million USD | 24.55% |
| 2014 Q3 | 299.3 Million USD | 12.08% |
| 2014 Q2 | 267.05 Million USD | 16.8% |
| 2013 Q4 | 190.13 Million USD | 323.73% |
| 2013 FY | 190.13 Million USD | 77.67% |
| 2013 Q2 | -34.38 Million USD | -147.96% |
| 2013 Q1 | 71.69 Million USD | -33.0% |
| 2013 Q3 | -84.98 Million USD | -147.16% |
| 2012 Q3 | 95.51 Million USD | 43.63% |
| 2012 FY | 107.01 Million USD | 177.55% |
| 2012 Q2 | 66.5 Million USD | -26.36% |
| 2012 Q1 | 90.3 Million USD | 110.07% |
| 2012 Q4 | 107.01 Million USD | 12.04% |
| 2011 Q2 | -54.54 Million USD | 30.9% |
| 2011 Q3 | -2.05 Million USD | 96.24% |
| 2011 Q4 | 42.98 Million USD | 2196.0% |
| 2011 FY | 38.55 Million USD | 130.98% |
| 2011 Q1 | -78.92 Million USD | 36.6% |
| 2010 Q3 | -100.73 Million USD | 23.26% |
| 2010 Q1 | -127.04 Million USD | -1800.18% |
| 2010 Q2 | -131.26 Million USD | -3.32% |
| 2010 FY | -124.48 Million USD | -1761.8% |
| 2010 Q4 | -124.48 Million USD | -23.57% |
| 2009 Q4 | -6.68 Million USD | -106.08% |
| 2009 FY | -6.68 Million USD | -103.08% |
| 2009 Q1 | 259.57 Million USD | 19.4% |
| 2009 Q2 | 286.93 Million USD | 10.54% |
| 2009 Q3 | 109.94 Million USD | -61.68% |
| 2008 Q3 | 186.1 Million USD | -27.46% |
| 2008 Q4 | 217.4 Million USD | 16.82% |
| 2008 Q2 | 256.56 Million USD | 13.45% |
| 2008 Q1 | 226.15 Million USD | -18.56% |
| 2008 FY | 217.4 Million USD | -21.71% |
| 2007 Q4 | 277.7 Million USD | -1.48% |
| 2007 Q2 | 341.39 Million USD | -3.26% |
| 2007 FY | 277.7 Million USD | -21.16% |
| 2007 Q3 | 281.87 Million USD | -17.44% |
| 2007 Q1 | 352.9 Million USD | 0.19% |
| 2006 FY | 352.24 Million USD | 6.62% |
| 2006 Q3 | 344.81 Million USD | 10.26% |
| 2006 Q1 | 299.83 Million USD | -9.24% |
| 2006 Q4 | 352.24 Million USD | 2.16% |
| 2006 Q2 | 312.73 Million USD | 4.3% |
| 2005 FY | 330.36 Million USD | 33.98% |
| 2005 Q2 | 312.32 Million USD | 14.05% |
| 2005 Q1 | 273.85 Million USD | 11.06% |
| 2005 Q3 | 292.72 Million USD | -6.28% |
| 2005 Q4 | 330.36 Million USD | 12.86% |
| 2004 Q2 | 264.64 Million USD | -6.1% |
| 2004 Q1 | 281.83 Million USD | 104.1% |
| 2004 FY | 246.58 Million USD | 78.57% |
| 2004 Q4 | 246.58 Million USD | -17.84% |
| 2004 Q3 | 300.12 Million USD | 13.41% |
| 2003 Q4 | 138.08 Million USD | -10.09% |
| 2003 Q3 | 153.58 Million USD | 2.52% |
| 2003 FY | 138.08 Million USD | -7.39% |
| 2003 Q1 | 161.29 Million USD | 8.17% |
| 2003 Q2 | 149.8 Million USD | -7.12% |
| 2002 Q1 | 79.98 Million USD | -41.14% |
| 2002 Q4 | 149.1 Million USD | -4.67% |
| 2002 FY | 149.1 Million USD | 9.74% |
| 2002 Q3 | 156.4 Million USD | 22.14% |
| 2002 Q2 | 128.05 Million USD | 60.11% |
| 2001 Q2 | 115.07 Million USD | 77.33% |
| 2001 Q4 | 135.88 Million USD | 1.5% |
| 2001 FY | 135.88 Million USD | 74.97% |
| 2001 Q3 | 133.87 Million USD | 16.33% |
| 2001 Q1 | 64.89 Million USD | -16.44% |
| 2000 FY | 77.65 Million USD | 342.68% |
| 2000 Q2 | -234.82 Million USD | -7.76% |
| 2000 Q4 | 77.65 Million USD | 162.02% |
| 2000 Q3 | -125.21 Million USD | 46.68% |
| 2000 Q1 | -217.91 Million USD | -580.97% |
| 1999 FY | -32 Million USD | 34.96% |
| 1999 Q1 | -83 Million USD | -68.7% |
| 1999 Q2 | -52.9 Million USD | 36.27% |
| 1999 Q3 | -41.2 Million USD | 22.12% |
| 1999 Q4 | -32 Million USD | 22.33% |
| 1998 Q3 | -45.4 Million USD | -37.99% |
| 1998 Q4 | -49.2 Million USD | -8.37% |
| 1998 Q2 | -32.9 Million USD | 21.85% |
| 1998 Q1 | -42.1 Million USD | 15.8% |
| 1998 FY | -49.2 Million USD | 1.6% |
| 1997 Q2 | -11.2 Million USD | -41.77% |
| 1997 FY | -50 Million USD | -566.67% |
| 1997 Q4 | -50 Million USD | 2.34% |
| 1997 Q1 | -7.9 Million USD | -5.33% |
| 1997 Q3 | -51.2 Million USD | -357.14% |
| 1996 FY | -7.5 Million USD | 27.18% |
| 1996 Q1 | -12.4 Million USD | -20.39% |
| 1996 Q2 | -7.1 Million USD | 42.74% |
| 1996 Q3 | -19.5 Million USD | -174.65% |
| 1996 Q4 | -7.5 Million USD | 61.54% |
| 1995 Q2 | -7.2 Million USD | -26.32% |
| 1995 FY | -10.3 Million USD | -56.06% |
| 1995 Q3 | -5.5 Million USD | 23.61% |
| 1995 Q4 | -10.3 Million USD | -87.27% |
| 1995 Q1 | -5.7 Million USD | 13.64% |
| 1994 FY | -6.6 Million USD | 55.1% |
| 1994 Q1 | -12.6 Million USD | 14.29% |
| 1994 Q2 | -9.3 Million USD | 26.19% |
| 1994 Q3 | -3.5 Million USD | 62.37% |
| 1994 Q4 | -6.6 Million USD | -88.57% |
| 1993 Q4 | -14.7 Million USD | -1236.36% |
| 1993 Q3 | -1.1 Million USD | 0.0% |
| 1993 FY | -14.7 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -5575.883% |
| Alkermes plc | -166.73 Million USD | -1804.227% |
| Agenus Inc. | 274.13 Million USD | 1258.217% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 269.796% |
| Aptorum Group Limited | 1.35 Million USD | 234070.624% |
| Ardelyx, Inc. | 34.51 Million USD | 9299.957% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 74284.322% |
| Bicycle Therapeutics plc | -481.46 Million USD | -559.461% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 8879.938% |
| ChromaDex Corporation | -24.04 Million USD | -13103.131% |
| Chimerix, Inc. | -25.51 Million USD | -12343.034% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 45666.222% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -13310.014% |
| CRISPR Therapeutics AG | -150.84 Million USD | -2004.869% |
| Precision BioSciences, Inc. | -85.41 Million USD | -3617.468% |
| Dyadic International, Inc. | -6.37 Million USD | -49681.118% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -19827.754% |
| Fortress Biotech, Inc. | 7.66 Million USD | 41523.209% |
| Lantern Pharma Inc. | -21.7 Million USD | -14529.537% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -2772.422% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -37065.206% |
| IO Biotech, Inc. | -140.69 Million USD | -2156.654% |
| Jaguar Health, Inc. | 29.39 Million USD | 10902.929% |
| Novavax, Inc. | -298.29 Million USD | -964.416% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 59592.018% |
| Opthea Limited | 28.15 Million USD | 11376.197% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -18811.722% |
| ContextLogic Inc. | -232 Million USD | -1268.573% |
| MiMedx Group, Inc. | -33.9 Million USD | -9265.768% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 31243.59% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -136932.887% |
| NextCure, Inc. | -6.47 Million USD | -48920.982% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -6187.18% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -49674.087% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 26203.916% |
| Vaxcyte, Inc. | -368.22 Million USD | -762.264% |
| PDS Biotechnology Corporation | -32.7 Million USD | -9607.11% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 18476.485% |
| Pharming Group N.V. | 109.8 Million USD | 2991.597% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -18151.834% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -1711.955% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -17044.242% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -17044.242% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -44619.563% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -54082.406% |
| Acelyrin, Inc. | -216.9 Million USD | -1363.829% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -56494.258% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -184069.896% |
| Summit Therapeutics Inc. | 34.67 Million USD | 9256.974% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -46571.895% |
| Senti Biosciences, Inc. | 1.74 Million USD | 182576.379% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -1619.918% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -3999.481% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -52276.922% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 3182540.437% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 505687.42% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -2612.685% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1787.316% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 2963.795% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -41699.487% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -2359.136% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 46151.837% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -1210.055% |
| Immix Biopharma, Inc. | -17.5 Million USD | -18033.22% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -902.545% |
| MEI Pharma, Inc. | -3.7 Million USD | -85597.409% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 25478.379% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 2063.058% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 11524.06% |
| Fortress Biotech, Inc. | 7.66 Million USD | 41523.209% |
| Precigen, Inc. | -481 Thousand USD | -660001.663% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 22648.747% |
| AlloVir, Inc. | -62.69 Million USD | -4964.584% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -5609.154% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 5248.849% |
| ImmuCell Corporation | 10.99 Million USD | 28989.232% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -1959.793% |
| Onconetix, Inc. | 5.33 Million USD | 59654.094% |
| PureTech Health plc | -167.19 Million USD | -1799.011% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -10323.798% |
| Elevation Oncology, Inc. | -19.11 Million USD | -16507.851% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -64578.937% |
| Seer, Inc. | -4.24 Million USD | -74784.175% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -13109.173% |
| Innoviva, Inc. | 255.56 Million USD | 1342.39% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -5583.605% |
| ESSA Pharma Inc. | -33.62 Million USD | -9343.603% |
| GlycoMimetics, Inc. | -40.98 Million USD | -7647.062% |
| GT Biopharma, Inc. | -1.02 Million USD | -310878.355% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -4584.197% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 5283.226% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -2268.073% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -22814.903% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -10897.122% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -4214582.613% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -10188.021% |
| Aptose Biosciences Inc. | -8.19 Million USD | -38644.898% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -101372.379% |
| Soligenix, Inc. | -4.95 Million USD | -64022.525% |
| Century Therapeutics, Inc. | 847 Thousand USD | 374962.928% |
| Kura Oncology, Inc. | -20.11 Million USD | -15682.329% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -7658.122% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -37707.68% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 174393.117% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -99214.639% |
| Autolus Therapeutics plc | -186.59 Million USD | -1601.557% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -6339.82% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -1051.254% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 9365.463% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 2031.695% |
| GRI Bio, Inc. | -1.79 Million USD | -176883.779% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -35245.349% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -9447.13% |
| IGM Biosciences, Inc. | -72.6 Million USD | -4273.039% |
| INmune Bio, Inc. | -25.41 Million USD | -12394.939% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 2203.391% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -6167.571% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -19439.764% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -109957.901% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 8452.2% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -7609.333% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 10057.939% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 940.08% |
| Verastem, Inc. | -37.27 Million USD | -8417.327% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -34894.919% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -6022.188% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -20878.454% |
| Histogen Inc. | -7.48 Million USD | -42308.027% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -14594.846% |
| Surrozen, Inc. | -32.66 Million USD | -9620.454% |
| Organovo Holdings, Inc. | -1.5 Million USD | -210589.383% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -75434.627% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 16846.066% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 121471.904% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 76497.714% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -37783.691% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -7208.8% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -21681.707% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -902.272% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -439626.477% |
| Apollomics, Inc. | -27.39 Million USD | -11490.031% |
| Amarin Corporation plc | -191.04 Million USD | -1562.002% |
| Mesoblast Limited | 55.96 Million USD | 5773.55% |
| Turnstone Biologics Corp. | -14.58 Million USD | -21671.044% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -12453.728% |
| Synaptogenix, Inc. | -28.66 Million USD | -10977.889% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -339118.91% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 6615.409% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -368201.765% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -43597.413% |
| Exelixis, Inc. | -73.05 Million USD | -4246.46% |
| Better Therapeutics, Inc. | -860 Thousand USD | -369096.395% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -13122.375% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -1215.439% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 431459.28% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -42586.628% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 253296.89% |
| Gritstone bio, Inc. | 39.49 Million USD | 8140.236% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -3675.328% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -120527.664% |
| Avid Bioservices, Inc. | 169.72 Million USD | 1970.693% |
| Insmed Incorporated | 721.62 Million USD | 539.995% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -34632.646% |
| MediWound Ltd. | -5.32 Million USD | -59559.696% |
| OmniAb, Inc. | 9.2 Million USD | 34600.587% |
| Alector, Inc. | -35.63 Million USD | -8809.529% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 3793.209% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -64329.566% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 24082.846% |
| Zai Lab Limited | -775 Million USD | -309.689% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 1032.328% |
| Aura Biosciences, Inc. | -21.52 Million USD | -14650.704% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -3749.526% |
| Immunic, Inc. | -45.34 Million USD | -6902.843% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -1543.293% |
| Veracyte, Inc. | -203.82 Million USD | -1457.76% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 597.434% |
| FibroGen, Inc. | 56.76 Million USD | 5693.195% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 35755.126% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -112209.76% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -153260.16% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 169.169% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -94934.092% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1813.119% |
| TG Therapeutics, Inc. | 17.86 Million USD | 17875.663% |
| Galecto, Inc. | -21.21 Million USD | -14865.54% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -13249.123% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 302.312% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -12874.375% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -27492.674% |
| XBiotech Inc. | -200.02 Million USD | -1487.362% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -3675.328% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 70221.223% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -8904.024% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -4011.851% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 55891.407% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -1763.151% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -3337.211% |
| Vaxxinity, Inc. | 10.13 Million USD | 31437.238% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 531.242% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -29387.569% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -4713.95% |
| NexImmune, Inc. | -3.13 Million USD | -101222.614% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -91860.316% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -20911.147% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -11616.196% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -35272.886% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -2548636.905% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -7725.813% |
| Ainos, Inc. | 4.07 Million USD | 77960.35% |
| Pluri Inc. | 22.82 Million USD | 14008.139% |
| Prothena Corporation plc | -608.34 Million USD | -421.921% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -2573.624% |
| Celularity Inc. | 65.19 Million USD | 4970.515% |
| Rallybio Corporation | -24.1 Million USD | -13073.55% |
| Cue Biopharma, Inc. | -33.81 Million USD | -9288.477% |
| MeiraGTx Holdings plc | -40.3 Million USD | -7778.242% |
| Omeros Corporation | 331.17 Million USD | 1058.732% |
| Humacyte, Inc. | -22.48 Million USD | -14020.293% |
| Immunocore Holdings plc | -358.59 Million USD | -785.427% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -12819.996% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -10175.036% |
| Blueprint Medicines Corporation | 702.83 Million USD | 551.754% |
| CalciMedica, Inc. | -5.53 Million USD | -57315.714% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -1586.903% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -30985.657% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -7830.387% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -9448.278% |
| Pulmatrix, Inc. | -10.41 Million USD | -30379.879% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -53021.784% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -8224.39% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -2750.118% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -5196.758% |
| Cytokinetics, Incorporated | 642.37 Million USD | 594.276% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -54426.687% |
| Nutriband Inc. | -251.65 Thousand USD | -1261573.23% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -9205.926% |
| Vor Biopharma Inc. | 4.3 Million USD | 73939.279% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 47.397% |
| Evogene Ltd. | -19.63 Million USD | -16071.381% |
| ProKidney Corp. | -56.23 Million USD | -5546.008% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -6423.441% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -34272.899% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 332.794% |
| CorMedix Inc. | -43.05 Million USD | -7274.923% |
| BioLineRx Ltd. | 7.33 Million USD | 43380.93% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -11460.492% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 6980.38% |
| Atai Life Sciences N.V. | -28.55 Million USD | -11018.037% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 142446.905% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -13816.063% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 18002.955% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -4129.279% |
| MediciNova, Inc. | -50.78 Million USD | -6152.204% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -3929.045% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -14114543.254% |
| GeoVax Labs, Inc. | -6.45 Million USD | -49106.435% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -1488.967% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1806.159% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -1674.041% |
| Mereo BioPharma Group plc | -51.46 Million USD | -6068.935% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -3247.696% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -980.848% |
| Absci Corporation | -72.59 Million USD | -4273.521% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 69637.648% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -1254.346% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -3270.189% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -3217.891% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -8026.044% |
| Allakos Inc. | -24.97 Million USD | -12613.069% |
| Imunon, Inc. | -4.21 Million USD | -75248.849% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -21437.709% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -2244.97% |
| BioAtla, Inc. | -109.01 Million USD | -2812.632% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 431459.28% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -338035.144% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 26634.255% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -14874.716% |
| XOMA Corporation | -29 Million USD | -10848.583% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -19073.243% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -35116.16% |
| aTyr Pharma, Inc. | -7.44 Million USD | -42524.366% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -2447.489% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -1425.282% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -3782.524% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -3322.797% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -369447.035% |
| Akari Therapeutics, Plc | -3.84 Million USD | -82477.087% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 195744.129% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 329.933% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -267133.016% |
| UroGen Pharma Ltd. | 4.39 Million USD | 72409.018% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 2897.904% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 4412274.481% |
| Orgenesis Inc. | 21.78 Million USD | 14675.326% |
| Entera Bio Ltd. | -10.62 Million USD | -29771.945% |
| GH Research PLC | -78.07 Million USD | -3966.612% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -14145.733% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -11810.008% |
| Xencor, Inc. | 29.64 Million USD | 10810.731% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -161087.413% |
| Replimune Group, Inc. | 1.41 Million USD | 224964.66% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -1296341.521% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -2411.6% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -267133.016% |
| Portage Biotech Inc. | -4.98 Million USD | -63644.007% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -14114543.254% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -4701.865% |
| OncoCyte Corporation | -6.56 Million USD | -48278.623% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 353904.659% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -69595.738% |
| Purple Biotech Ltd. | -14.13 Million USD | -22357.837% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -13265.419% |
| scPharmaceuticals Inc. | -6.54 Million USD | -48411.673% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -18921.433% |
| HilleVax, Inc. | -165.48 Million USD | -1818.657% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -125002.009% |
| Tharimmune, Inc. | -10.93 Million USD | -28935.087% |
| Genprex, Inc. | -6.73 Million USD | -47024.723% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -760.908% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -3489.293% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -226530.193% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -95623.265% |
| OKYO Pharma Limited | -826.84 Thousand USD | -383899.115% |
| Savara Inc. | 153 Thousand USD | 2075321.569% |
| Curis, Inc. | -23.88 Million USD | -13192.121% |
| Daré Bioscience, Inc. | -5.15 Million USD | -61457.654% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -409054.626% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -51045.119% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 268040.0% |
| BeiGene, Ltd. | -2.25 Billion USD | -40.922% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 25833.185% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -422.043% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -1610.845% |
| Erasca, Inc. | -37.21 Million USD | -8431.516% |
| bluebird bio, Inc. | 108.57 Million USD | 3024.436% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -246433.602% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 938.312% |
| DBV Technologies S.A. | -126.98 Million USD | -2400.346% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -246433.602% |
| Moderna, Inc. | -2.9 Billion USD | -9.222% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -30571.262% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -29115.026% |
| Molecular Templates, Inc. | 707 Thousand USD | 449193.211% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -10021.096% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 1016.046% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -3769.134% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -3361.342% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -9738.526% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -9136.354% |
| MacroGenics, Inc. | -66.98 Million USD | -4640.0% |
| RenovoRx, Inc. | -1.17 Million USD | -270581.074% |
| Adicet Bio, Inc. | -138.78 Million USD | -2187.742% |
| Prime Medicine, Inc. | -27.94 Million USD | -11263.548% |
| Aditxt, Inc. | 18.12 Million USD | 17621.71% |
| Adagene Inc. | -87.62 Million USD | -3523.398% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -76124.796% |
| Quantum-Si incorporated | -118.55 Million USD | -2578.112% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 8918.467% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -42380.722% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -6445.361% |
| SciSparc Ltd. | -2.06 Million USD | -153657.337% |
| Vericel Corporation | 1.27 Million USD | 248736.57% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -26377.386% |
| Minerva Neurosciences, Inc. | 41 Million USD | 7843.317% |
| Generation Bio Co. | 31.44 Million USD | 10196.315% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -1710.571% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -10167.726% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 2823.224% |
| Invivyd, Inc. | -198.47 Million USD | -1499.734% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -3417.325% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -132322.928% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -4385.222% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -46421.451% |
| 2seventy bio, Inc. | 181.71 Million USD | 1847.291% |
| ADMA Biologics, Inc. | 90.06 Million USD | 3625.291% |
| Clene Inc. | 3.34 Million USD | 95162.545% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -34857.534% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -14660.304% |
| GeoVax Labs, Inc. | -6.45 Million USD | -49106.435% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -822.658% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -12112.03% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 1887.111% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -77500.807% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 63576.389% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -60853.907% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -2336.678% |
| Evaxion Biotech A/S | 5.28 Million USD | 60156.416% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -2720.596% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -2318.692% |
| Trevena, Inc. | 2.25 Million USD | 140715.102% |
| Surrozen, Inc. | -32.66 Million USD | -9620.454% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -6064.024% |
| Cingulate Inc. | 3.08 Million USD | 103097.584% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -108006.537% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 44278.225% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -34072.978% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -3902.734% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -2315.398% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -2908.365% |
| Clearmind Medicine Inc. | -3.94 Million USD | -80432.116% |
| Kronos Bio, Inc. | -36.05 Million USD | -8706.482% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 33845.233% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 217851.197% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -5752.051% |
| Statera Biopharma, Inc. | 14.41 Million USD | 22124.137% |
| ImmunityBio, Inc. | 618.22 Million USD | 613.582% |
| Korro Bio, Inc. | -132.94 Million USD | -2288.309% |
| Kineta, Inc. | -4.54 Million USD | -69820.48% |
| BioVie Inc. | -17.73 Million USD | -17805.629% |
| Codexis, Inc. | -43.27 Million USD | -7237.683% |
| Celularity Inc. | 65.19 Million USD | 4970.515% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -100092.143% |
| Celcuity Inc. | 6.78 Million USD | 46905.997% |
| Virax Biolabs Group Limited | -3.36 Million USD | -94257.856% |
| Cibus, Inc. | -8.07 Million USD | -39205.385% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -74978.955% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 69576.783% |
| IN8bio, Inc. | -16.38 Million USD | -19273.293% |
| Kodiak Sciences Inc. | -103.87 Million USD | -2956.644% |
| Annexon, Inc. | -193.75 Million USD | -1538.713% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 8819791.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -18044.403% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -90281.127% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 401.164% |
| Eyenovia, Inc. | 1.25 Million USD | 252351.049% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 11901.111% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -97805.92% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -9450.002% |
| Arcellx, Inc. | -296.95 Million USD | -969.205% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -16177.499% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -5292.932% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -15218.613% |
| Moolec Science SA | 117.61 Thousand USD | 2699638.328% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -8168.676% |
| Geron Corporation | 14.76 Million USD | 21609.986% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -8273.567% |
| Royalty Pharma plc | 5.65 Billion USD | 156.114% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -2145.133% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -45327.048% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -59105.155% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -2156.14% |
| Humacyte, Inc. | -22.48 Million USD | -14020.293% |
| Structure Therapeutics Inc. | -124.33 Million USD | -2453.574% |
| 89bio, Inc. | -289.05 Million USD | -998.445% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -12478.595% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -177975.659% |
| Genelux Corporation | -6.89 Million USD | -45922.453% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -10122.766% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 3897.999% |
| Notable Labs, Ltd. | -9.77 Million USD | -32378.406% |
| Liquidia Corporation | -80.17 Million USD | -3860.149% |
| Mustang Bio, Inc. | -3.73 Million USD | -84886.322% |
| Immunovant, Inc. | -635.22 Million USD | -399.835% |
| Quantum-Si incorporated | -118.55 Million USD | -2578.112% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -17977.255% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -76537.437% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 39655.114% |
| Acasti Pharma Inc. | -23 Million USD | -13701.734% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -94193.824% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -19439.764% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -2205.132% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -101784.473% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -14181.617% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -16998.869% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -1775.665% |
| PepGen Inc. | -60.67 Million USD | -5133.376% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -13719.155% |
| United Therapeutics Corporation | -507.7 Million USD | -525.387% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -16500.905% |
| Solid Biosciences Inc. | -47.75 Million USD | -6549.401% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -368201.765% |
| Immuneering Corporation | -54.94 Million USD | -5678.893% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -75434.627% |
| Silo Pharma, Inc. | -3.52 Million USD | -89991.133% |
| Belite Bio, Inc | -87.27 Million USD | -3538.195% |
| XOMA Corporation | -29 Million USD | -10848.583% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -4391.123% |
| Bionomics Limited | 227 Million USD | 1498.657% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -2630.508% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -125248.954% |
| uniQure N.V. | -102.95 Million USD | -2984.078% |
| Cassava Sciences, Inc. | -121.13 Million USD | -2521.094% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -76124.796% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 7853.386% |
| Forte Biosciences, Inc. | -11.96 Million USD | -26445.347% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -102514.214% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 2995466.981% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -97805.92% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 35755.126% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -42714.037% |
| Altimmune, Inc. | -134.48 Million USD | -2260.889% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 1703.054% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -125248.954% |
| Compugen Ltd. | -12.9 Million USD | -24505.463% |
| Peak Bio, Inc. | 10.34 Million USD | 30806.388% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -1121839.576% |
| Benitec Biopharma Inc. | -50.58 Million USD | -6177.112% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -2943.08% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 16262.326% |
| Zura Bio Limited | -99.8 Million USD | -3081.261% |
| PolyPid Ltd. | 6.17 Million USD | 51560.113% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 4383.714% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 16262.326% |
| Instil Bio, Inc. | 75.35 Million USD | 4313.34% |
| argenx SE | -2.02 Billion USD | -56.497% |
| Immunome, Inc. | -97.02 Million USD | -3172.309% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -14014.643% |
| Verona Pharma plc | -220.44 Million USD | -1340.322% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -4325.643% |
| Shattuck Labs, Inc. | -121.42 Million USD | -2514.878% |
| CervoMed Inc. | -7.79 Million USD | -40643.638% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -1611.648% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -72506.654% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -2310.118% |
| Moolec Science SA | 117.61 Thousand USD | 2699638.328% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -138672.767% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 20071.148% |
| AnaptysBio, Inc. | -18.15 Million USD | -17392.64% |
| Design Therapeutics, Inc. | -18.15 Million USD | -17393.603% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -4411.287% |
| NeurAxis, Inc. | 145.7 Thousand USD | 2179296.294% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 28368.243% |
| Lumos Pharma, Inc. | -28.49 Million USD | -11043.4% |
| Achilles Therapeutics plc | -126.92 Million USD | -2401.567% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -4325.643% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -484106.762% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -15184.085% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 217851.197% |
| Nutriband Inc. | -251.65 Thousand USD | -1261573.23% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -24006.666% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -42575.927% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 1033.309% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 13477.245% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -609.562% |
| Palisade Bio, Inc. | -12.06 Million USD | -26220.89% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -2162.894% |
| Beam Therapeutics Inc. | -262.72 Million USD | -1108.536% |
| Neurogene Inc. | -131.95 Million USD | -2306.191% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 14653.947% |
| AEON Biopharma, Inc. | -4.88 Million USD | -64963.299% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -741.772% |
| Sesen Bio, Inc. | -112.55 Million USD | -2720.972% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -3079.54% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -135137.178% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -8035.83% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -3712.455% |
| Athira Pharma, Inc. | -88.99 Million USD | -3467.556% |
| Vaccinex, Inc. | -1.28 Million USD | -246413.121% |
| HCW Biologics Inc. | 2.85 Million USD | 111246.276% |
| XOMA Corporation | -29 Million USD | -10848.583% |
| Nektar Therapeutics | 210.24 Million USD | 1610.221% |
| Arvinas, Inc. | -313.8 Million USD | -911.819% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 195744.129% |
| Merus N.V. | -192.88 Million USD | -1546.113% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 5393.138% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -45663.75% |
| Rezolute, Inc. | -68.16 Million USD | -4557.741% |
| Clene Inc. | 3.34 Million USD | 95162.545% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -23977.417% |
| BeyondSpring Inc. | -13.75 Million USD | -22983.162% |
| Synlogic, Inc. | -6.68 Million USD | -47395.722% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 280090.212% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -37452.797% |
| Peak Bio, Inc. | 10.34 Million USD | 30806.388% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -3752.328% |
| Krystal Biotech, Inc. | -350.23 Million USD | -806.562% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 2657.977% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -1778.795% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -100468.393% |
| MannKind Corporation | 143.89 Million USD | 2306.471% |
| Ikena Oncology, Inc. | -109.15 Million USD | -2808.763% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -41837.512% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -9492.414% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1860.466% |
| CohBar, Inc. | -5.93 Million USD | -53436.217% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -10573.286% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 69637.648% |
| Legend Biotech Corporation | -949.39 Million USD | -234.432% |
| Mural Oncology plc | -255.84 Million USD | -1141.03% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 9955.934% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -67302.469% |
| Disc Medicine, Inc. | -358.28 Million USD | -786.201% |
| Champions Oncology, Inc. | 4.81 Million USD | 66082.731% |
| REGENXBIO Inc. | 54.76 Million USD | 5897.343% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -1180638.694% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -2002.374% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -35131.767% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -3835.264% |
| Vaxart, Inc. | -8.24 Million USD | -38427.958% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -6227.403% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -2396.813% |
| Cellectis S.A. | -43.85 Million USD | -7139.97% |
| Longeveron Inc. | -2.9 Million USD | -109084.629% |
| Repare Therapeutics Inc. | -107.85 Million USD | -2843.768% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 427.877% |
| Inozyme Pharma, Inc. | 12 Million USD | 26550.258% |
| Revolution Medicines, Inc. | -608.2 Million USD | -422.043% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -258037.317% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -1097.618% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -2015.71% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -20191.998% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -428966.081% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 66.801% |
| Denali Therapeutics Inc. | -74.86 Million USD | -4141.086% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -26377.386% |
| Veru Inc. | 4.77 Million USD | 66524.887% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -28133.052% |
| Cingulate Inc. | 3.08 Million USD | 103097.584% |
| Passage Bio, Inc. | 4.58 Million USD | 69349.487% |
| Context Therapeutics Inc. | -14.44 Million USD | -21873.197% |
| Exicure, Inc. | 5.84 Million USD | 54384.305% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -1278.22% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -7923.98% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 20335.097% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -5297.883% |
| Nuvalent, Inc. | -335.38 Million USD | -846.694% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 183171.783% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -4162.894% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -35615.287% |
| OmniAb, Inc. | 9.2 Million USD | 34600.587% |
| Anew Medical, Inc. | 1.43 Million USD | 221752.117% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 19481.861% |
| Lipocine Inc. | -4.75 Million USD | -66679.421% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -2790.965% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 20946.228% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -6167.571% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 12855.46% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -47141.318% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -4723.384% |
| Ocugen, Inc. | -32.52 Million USD | -9663.196% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -3610.3% |
| Q32 Bio Inc. | -37.94 Million USD | -8266.947% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -505487.42% |
| Alumis Inc. Common Stock | -13.52 Million USD | -23368.763% |
| Equillium, Inc. | -22.39 Million USD | -14079.569% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -12318.214% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -9631.546% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -1280616.778% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 2468.727% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 99383.583% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 966815.179% |
| Dominari Holdings Inc. | 195 Thousand USD | 1628350.769% |
| Edesa Biotech, Inc. | -5.26 Million USD | -60183.715% |
| vTv Therapeutics Inc. | -8.91 Million USD | -35507.144% |
| Bio-Techne Corporation | 267.74 Million USD | 1285.854% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -19488.432% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -2588.612% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -37685.184% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -24997.534% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -1195.326% |
| Nkarta, Inc. | 57.29 Million USD | 5641.264% |
| BioCardia, Inc. | 212 Thousand USD | 1497783.491% |
| Iterum Therapeutics plc | 13.43 Million USD | 23727.69% |